首页>
外国专利>
RECOMBINANT PLASMID DNA PESG ENCODING FUSED PROTEIN SYNTHESIS THAT SHOWS ANTIGENIC PROPERTY OF HUMAN T-CELLULAR LEUKOSIS I-TYPE VIRUS SURFACE GLYCOPROTEID ENVELOPE (HTLV-I), METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIUM ESCHERICHIA COLI HB 101/PESG - PRODUCER OF FUSED PROTEIN
RECOMBINANT PLASMID DNA PESG ENCODING FUSED PROTEIN SYNTHESIS THAT SHOWS ANTIGENIC PROPERTY OF HUMAN T-CELLULAR LEUKOSIS I-TYPE VIRUS SURFACE GLYCOPROTEID ENVELOPE (HTLV-I), METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIUM ESCHERICHIA COLI HB 101/PESG - PRODUCER OF FUSED PROTEIN
展开▼
机译:重组融合质粒DNA PESG编码融合蛋白的合成,显示人类T细胞白血病I型病毒表面糖蛋白包膜(HTLV-I)的抗原性,其构建方法和菌株大肠杆菌蓝球菌肠球菌HB 101 / PE
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: genetic engineering, biotechnology. SUBSTANCE: recombinant plasmid DNA PESG (size is 5.6 thousand nucleotide pairs) consists of SalGI-BamHI-fragment (426 nucleotide pairs) of region sequence env HTLV-I and SalGI-fragment of plasmid pUR291 (size is 5.2 thousand nucleotide pairs) with beta-galactosidase gene, region ori and genetic marker as bla-gene (resistance to ampicillin) and has the unique restriction sites to BamHI, PstI, HindIII, StuI, ClaI, Tth111-II. Fragment (size is 426 nucleotide pairs) is excised from intermediate plasmid pBE1 using restriction enzyme SalGI and this fragment is ligated with SalGI-fragment of plasmid vector DNA pUR291 linearized by hydrolysis. After incubation competence cells of E. coli (treated with CaCl2) were transformed with obtained preparation followed by selection of transformants according their capability to grow on ampicillin-containing medium. Proposed invention ensures to obtain 400-500 mg fused protein from 1 l cell suspension of E. coli that contains specific polypeptide sequence encoded by region env of genome HTLV-I. EFFECT: construction of recombinant plasmid DNA, high level of fused protein production, construction of the strain-producer indicated above.
展开▼